Skip to main content
. 2022 Jul 27;12(3):2333–2344. doi: 10.1002/cam4.5056

FIGURE 5.

FIGURE 5

(A) Progression‐free survival of patients prior treated with (n = 44) and without (n = 128) lapatinib; (B) Progression‐free survival of patients with (n = 141) and without (n = 31) visceral metastases.